Zydus Lifesciences gets FDA final approval for Oxcarbazepine tablets
Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to produce and sell Oxcarbazepine tablets in strengths of 150 mg, 300 mg, and 600 mg. Oxcarbazepine tablets is the generic of Trileptal Tablets, a drug commonly used to treat seizure disorders like epilepsy. This significant approval allows Zydus Lifesciences to […]